ErasmusMC.Urology.Research

Updates, publications and news from the Erasmus MC Urology Research Department

[ProstateCancer2050 @Urology2050]

Dianne Baunbeck ran 22.000 kilometers to hit her goal. In Prostate Cancer 2050 she presents the goals for liquid biopsies in diagnostics and precision medicine. Determined for success. Join to mix in the discussion.

[ProstateCancer2050 @Urology2050]

Dr Veeru Kasivivanathan from London had his prime time at EAU 2024 in Paris showing with the PRIME study that bp MRI serves equal to mp MRI for the detection of prostate cancer. Meet him at the PCa 20250 sustainability symposium in Rotterdam 19-20 September 2024!

[ErasmusMC.Urology.Research @EMCUrolResearch]

@Urology2050 Great opportunity to meet with colleagues that make the future!

[ProstateCancer2050 @Urology2050]

And the junior faculty:

[ErasmusMC.Urology.Research @EMCUrolResearch]

@Urology2050 Prof Arno van Leenders pathologist in his inaugural speech today showed us that you can start young being fascinated by postate cancer research … so start before 2050!

[ProstateCancer2050 @Urology2050]

We are proud to announce a congress on the sustainability of prostate cancer care.A multinational junior and senior faculty from Sweden, Germany, France, Hungary, Japan and The Netherlands has joined on organizing a green meeting in September 2024 in Rotterdam, The Netherlands.

[ErasmusMC.Urology.Research @EMCUrolResearch]

With a relatively simple test, urologist may accurately determine in the future which patients will benefit from BCG bladder instillations. In 30/50% percent of patients, treatment is not successful, while treatment duration is lengthy and unpleaseant.
https://t.co/2lcqoAFDJP

[ErasmusMC.Urology.Research @EMCUrolResearch]

@TCMZuiverloon discussed the state-of-the-art patient-derived organoid technology at the first day of #EAU22. A preclinical model to investigate chemoresistance in muscle-invasive bladder cancer.
#organoid #bladdercancer #MIBC

[ErasmusMC.Urology.Research @EMCUrolResearch]

The IMPASSE study https://t.co/fvAE9VmwPE will investigate if our previously developed BCG Response Subtypes https://t.co/lIC11tEJue can be prospectively validated, and determines if targeted therapies using PDx tumoroid models are feasible. @bkcrotterdam @TCMZuiverloon @FCdeJong

[ErasmusMC.Urology.Research @EMCUrolResearch]

Great work from our international collaboration: Non-muscle Invasive Bladder Cancer Molecular Subtypes Predict Differential Response to Intravesical BCG https://t.co/pLPwhvtlll @FCdeJong @Dan_Theodorescu @TCMZuiverloon @joostboormans @EmielJanssen7 @ellen_zwarthoff @TDLaajala

[ErasmusMC.Urology.Research @EMCUrolResearch]

The prediction of biochemical recurrence after radical prostatectomy can be improved with detailed pathology. Read more about our latest research here: https://t.co/8LbCekTLU8 @MoniqueRoobol @joostboormans @ChrisBangma @JensterGuido

[Elena Martens @MartensUS]

Delighted to share our research letter to @EUplatinum European Urology (IF 20) highlighting our recent position paper in @ISEV_JEV (IF 21) on the need of rigor and standardization in #extracellular_vesicle research! @EMCUrolResearch @IsevComms @WebEVTalk https://t.co/rQNEwPIJLc

[ErasmusMC.Urology.Research @EMCUrolResearch]

Upcoming weekend is exciting, as the #EAU21 will take place! As a group, we have several interesting presentations and abstracts accepted. Want to know when? See: https://t.co/lt6FUtaoaW @bkcrotterdam
@Uroweb @joostboormans @ellen_zwarthoff @JoepJdeJong @FCdeJong @ChrisBangma

[ErasmusMC.Urology.Research @EMCUrolResearch]

Congratulations @bertilblok ! @bkcrotterdam @ChrisBangma @ErasmusMC @Uroweb
https://t.co/T7HjsdoiBI

[ErasmusMC.Urology.Research @EMCUrolResearch]

Excellent international research and amazing work from our head of department and head investigator @joostboormans. Certainly, bladder cancer immune therapy will improve patient care worldwide. https://t.co/kDDE3yDys6

[ErasmusMC.Urology.Research @EMCUrolResearch]

Great work on exosomes by our cancer scientists! @ChrisBangma @bkcrotterdam @Uroweb @joostboormans @TCMZuiverloon @JensterGuido

[Elena Martens @MartensUS]

Our #JEV position paper on #urinaryEV is fully accessible online :) !!!
https://t.co/SbQ6pmsWFX
@IsevComms @IsevOrg @NLSEV_ @SNEVresearch @exRNA @ExosomeRNA @UKEVSoc @BESEV_ @ASEV_Austria @EVItaSociety @IsrevR @GSEV10 @WebEVTalk @Marvel_H2020 @EUplatinum @Uroweb @French_Soc_EVs

[ErasmusMC.Urology.Research @EMCUrolResearch]

Erasmus MC Sophia Research Day Best Presentation (Slam session 1) was awarded to Mathijs Scholtes: Bladder cancer organoids as a near-patient model to study treatment response in muscle-invasive bladder cancer (2021).

[ErasmusMC.Urology.Research @EMCUrolResearch]

Een geweldige Q&A over prostaatkanker van Professor Bangma @ChrisBangma https://t.co/F56hMk642A

[ErasmusMC.Urology.Research @EMCUrolResearch]

Excellent work from Luiting et al: Performing an MRI before starting active surveillance reduces the cumulative probability of discontinuing active surveillance in prostate cancer https://t.co/HKI9VExNxo

[ErasmusMC.Urology.Research @EMCUrolResearch]

Great work from @FCdeJong @TCMZuiverloon @joostboormans @JoepJdeJong @ellen_zwarthoff and Robert Hoedemaeker @bkcrotterdam @Franciscuszorg @AmphiaZKHuis

[Journal of Urology @JUrology]

Open Access Article from the March 2021 Issue:

T1 Substaging of Nonmuscle Invasive #BladderCancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis

Read the full text here: https://t.co/Mq8q3m6FLP
@FCdeJong